Universal Health Realty Income Trust Reports Q1 Net Income of $5.019 Million
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 27 2026
0mins
Source: moomoo
Universal Health Reality: The article discusses the financial performance of Universal Health Reality, highlighting its net income for the first quarter.
Net Income Report: Universal Health Reality reported a net income of USD 5.019 million for Q1, indicating its financial health and operational success.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UHT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UHT
About UHT
Universal Health Realty Income Trust is a real estate investment trust. The Company invests in healthcare and human service related facilities, including acute care hospitals, behavioral healthcare hospitals, specialty facilities, free-standing emergency departments, childcare centers and medical/office buildings. The Company has approximately 76 real estate investments or commitments located in 21 states in the United States consisting of six hospital facilities including three acute care and three behavioral healthcare; 60 medical/office buildings; four free-standing emergency departments; four preschool and childcare centers; one specialty facility located in Evansville, Indiana, and one property comprised of vacant land located in Chicago, Illinois. Its facilities include McAllen Medical Center, Wellington Regional Medical Center, Aiken Regional Medical Center, Canyon Creek Behavioral Health, Clive Behavioral Health, Desert Valley Medical Center and Danbury Medical Plaza.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Dividend Increase: Universal Health Realty Trust's Board of Trustees has voted to raise the quarterly dividend by $0.005 to $0.75 per share, scheduled for payment on June 30, 2026, reflecting the company's commitment to shareholder returns.
- Record Date for Shareholders: The dividend will be paid to shareholders of record as of June 22, 2026, ensuring timely cash inflow that enhances investor confidence and attracts potential investors.
- Diverse Investment Portfolio: The Trust holds 77 investments across 21 states, encompassing a variety of healthcare-related facilities such as acute care hospitals and behavioral health facilities, demonstrating its broad footprint and stability in the healthcare real estate sector.
- Market Positioning: As a real estate investment trust focused on healthcare and human services facilities, Universal Health Realty Trust's growth potential aligns with the ongoing demand in the healthcare industry, which is expected to support future revenue growth.
See More
- Dividend Increase: Universal Health Realty Income Trust has announced a quarterly dividend increase of $0.005 to $0.75 per share, scheduled for payment on June 30, 2026, which is expected to enhance shareholder returns and boost investor confidence.
- Record Date for Shareholders: The record date for this dividend payment is set for June 22, 2026, ensuring that eligible shareholders receive the increased returns in a timely manner, thereby strengthening the relationship between the company and its investors.
- Portfolio Overview: The Trust holds 77 investments across 21 states, including acute care hospitals, behavioral healthcare facilities, and rehabilitation hospitals, demonstrating its extensive footprint and influence in the healthcare real estate sector.
- Strategic Positioning: By consistently increasing dividends, Universal Health Realty not only enhances its market appeal but also showcases its stability and long-term growth potential in the healthcare services sector, attracting more investor interest.
See More
- Berkshire Hathaway Performance: Over the past year, Berkshire Hathaway's shares have declined by 2.8%, compared to a 4.3% drop in the insurance sector, indicating challenges in underwriting results due to catastrophic losses, although its strong cash position and diverse operations support financial flexibility.
- Eli Lilly Growth: Eli Lilly's stock has surged by 45.5% in the past year, significantly outperforming the 24% growth in the large-cap pharmaceuticals sector, driven by robust demand for its GLP-1 drugs, while new product launches contribute to substantial revenue growth.
- Walmart's Market Position: Walmart's shares increased by 22.1% over the past year, surpassing the 18.5% growth in the retail supermarket industry, with its scale and expanding omnichannel ecosystem enhancing competitiveness, despite challenges from fuel costs and policy uncertainties.
- Utah Medical Products: Utah Medical Products' shares rose by 27.6% in the past year, reflecting a strong balance sheet with no debt, although a 10.2% revenue decline in Q1 highlights execution risks, yet favorable long-term trends in the medical device sector remain promising.
See More
- Earnings Per Share: Universal Health REIT reported a Q1 GAAP EPS of $0.36, indicating resilience in maintaining profitability despite economic fluctuations, which is crucial for investor confidence in uncertain markets.
- Slight Revenue Decline: The revenue for the first quarter was $24.53 million, reflecting a minor year-over-year decrease of 0.1%, suggesting that increased competition in the healthcare REIT sector may pressure future revenue growth, warranting close monitoring of market trends.
- Investor Appeal: Universal Health REIT is viewed as a solid income investment through economic cycles, highlighting its stable cash flow and dividend policy, which may attract income-seeking investors and enhance its market appeal.
- Financial Transparency: The company has provided comprehensive financial information and historical earnings data, which boosts investor confidence in its financial health and offers potential investors a solid basis for decision-making, thereby increasing market interest in its stock.
See More
- Net Income Growth: In Q1 2026, Universal Health Services reported net income of $348.7 million, or $5.65 per diluted share, compared to $316.7 million and $4.80 per diluted share in Q1 2025, indicating a significant improvement in profitability and reflecting strong performance in the healthcare sector.
- Significant Revenue Increase: The net revenues for Q1 2026 reached $4.495 billion, a 9.6% increase year-over-year, demonstrating sustained demand in acute care and behavioral health services, which enhances the company's competitive position in the industry.
- Strong EBITDA Performance: The EBITDA for Q1 2026 was $651.7 million, up 9.5% from $603.9 million in Q1 2025, showcasing ongoing improvements in operational efficiency and cost control, further solidifying the company's financial health.
- Robust Cash Flow: The net cash provided by operating activities for Q1 2026 was $402 million, an increase of $42 million from $360 million in 2025, reflecting significant enhancements in cash management and operational efficiency, thereby strengthening the company's capacity for future investments and expansion.
See More
- Net Income Growth: For Q1 2026, Universal Health Realty reported a net income of $5 million, or $0.36 per diluted share, reflecting an increase from $4.8 million and $0.34 per diluted share in Q1 2025, primarily driven by reduced interest expenses and increased property income, thereby enhancing the company's profitability.
- Funds from Operations Performance: The FFO for the first quarter was $12.3 million, or $0.88 per diluted share, up from $11.9 million and $0.86 per diluted share in Q1 2025, indicating significant operational efficiency improvements amid rising revenues and depreciation expenses.
- Dividend Payment Update: A dividend of $0.745 per share, totaling $10.3 million, was declared for Q1 2026 and paid on March 31, demonstrating the company's ongoing commitment to stable cash flow and shareholder returns.
- Credit Agreement Amendment: In April 2026, the company increased its borrowing capacity under its credit agreement from $425 million to $475 million, with the maturity date remaining unchanged at September 30, 2028, enhancing financial flexibility and supporting future investment strategies.
See More









